Induction and progression of human lymphoproliferative lesions by Epstein-Barr virus. by Chappuis, B B & Müller-Hermelink, H K
EnvironmentalHealthPerspectives
Vol. 88, pp. 237-241, 1990
Induction and Progression of Human
Lymphoproliferative Lesions by
Epstein-Barr Virus
by Bettina Borisch Chappuis* and Hans Konrad Muller-
Hermelink*
Epstein-Barr virus (EBV) is involved in numerous lymphoproliferative diseases. In addition to classical
lesions such as endemic Burkitt's lymphoma and infectious mononucleosis, there are other disorders of
the lymphoid system that are discussed in relation to EBV: B-cell lymphomas in immunosuppressed
individuals, Hodgkin's disease and, to some extent, primary extranodal lymphomas. Studies of the EBV
expression in classical and nonclassical lesions could lead to the better understanding of different EBV
mechanisms in lymphomagenesis.
Introduction
Epstein-Barr virus (EBV) is intimately linked with
some well-described lesions ofthe lymphoid system (1).
However, the basic mechanisms of EBV-associated
lymphomagenesis are not yet fully understood. The
study of EBV-induced lymphoproliferative disease
(LPD) in immunodeficiency (2) has been very helpful in
this context. Recently, EBV involvement in tumors of
the lymphoid system other than the classical ones is
being discussed again. One ofthe lesions under consid-
eration is Hodgkin's disease (3); another condition is T-
cell lymphoma (4). Further, the involvement ofEBV in
extranodal lymphomas of various origins is suggested
(5). In this report we discuss the distribution of EBV
in lymphoid lesions. Inaddition, morphological evidence
of different EBV expression in reactive and tumorous
lesions is presented.
Materials and Methods
Five hundred thirty-nine cases with an eventual as-
sociation with EBV were collected from the ifies ofthe
Institute of Pathology Wurzburg or were a gift from
various other colleagues to whom we are greatly in-
debted. Most of the cases were lymphomas and LPD.
Five nasopharyngeal carcinomas and six cases ofinfec-
tious mononucleosis (IM) were included for control pur-
poses. African lymphomas and lymph nodes came from
Uganda, Rwanda, and Tanzania. All other lesions were
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from Central Europe. The results presented were ob-
tained with lymphomas in AIDS, LPD in inborn im-
munodeficiencies in children, and extranodal lympho-
mas.
All lesions were studied morphologically and immu-
nohistochemically. Theywere investigated forthe pres-
ence of EBV DNA by hybridization (dot or Southern
blot) with whole cellular DNA obtained from fresh or
paraffin material and appropriate EBV probes. In par-
allel, tissue sections were used for in situ hybridization
(ISH) to localize EBV DNA in the tissue. Molecular
biology studies made use of standard techniques (6).
DNA extraction from paraffin-embedded material was
carried out as described by Goelz et al. (7), ISH with
35S-labeledprobes andconsecutive autoradiographic de-
velopment for 1 to 5 weeks. Controls were as follows:
Raji cell DNA served as positive controls and IM and
nasopharyngeal carcinoma as positive cases. Negative
controls included unrelated lymphoid tissues (42 lym-
phadenitis) and hybridization with a cytomegalovirus
probe and omission ofthe specific probe.
Results
Lymphomas in AIDS, African Burkitt's
Lymphomas, and LPD in Inborn
Immunodeficiency
Histological classification and the main clinical data
are shown in Table 1. The LPD in children with inborn
immunodeficiencies were diagnosed according to Friz-
zera's proposition (8). Lymphomas were evaluated us-
ing the Kiel classification. The results obtained usingCHAPPUIS AND MULLER-HERMELINK
Table 1. Clinical data.
Case Agea Sex Tissue studied Histologic findings Clinical presentation
Children with immune defects
1 3 months M Liver, spleen Polymorphic B-cell lymphoma, thymic SCID (immunologically and clinically),
hypoplasia abdominal tumor
2 5 years F Lymph node Polymorphic B-cell hyperplasia, thymic Ill-defined immune defect (16)
hypoplasia
3 4 months M Brain, lymph node Polymorphic B-cell hyperplasia, thymic SCID (immunologically and clinically)
hypoplasia BMT, LPS
4 8 months F Lymph nodes Polymorphic B-cell lymphoma, thymic Immune defect mainly of the T-cell
dysplasia system
AIDS-associated lymphomas
5 25 years M Lymph node Immunoblastic lymphoma, T Nodal lymphoma, AIDS
6 33 years M Waldeyer's ring Burkitt's lymphoma Extranodal lymphoma, AIDS
7 54 years M Waldeyer's ring Unclassified lymphoma polymorph Extranodal lymphoma, AIDS
8 31 years M Tonsil Burkitt's lymphoma Extranodal lymphoma, AIDS
9 31 years M Lymph node Immunoblastic lymphoma, B Nodal lymphoma, AIDS
10 33 years M Lymph node Burkitt's lymphoma Nodal lymphoma, AIDS
11 28 years M Lymph node Burkitt's lymphoma Nodal lymphoma, AIDS
12 44 years M Lymph node Burkitt's lymphoma Nodal lymphoma, AIDS
13 26 years M Lymph node Burkitt's lymphoma Nodal lymphoma, AIDS
14 38 years M Lymph node Burkitt's lymphoma Nodal lymphoma, AIDS
15 44 years M Small intestine Large cell anaplastic Extranodal lymphoma, AIDS
16 29 years M os cribriforme Burkitt's lymphoma Extranodal lymphoma, AIDS
17 39 years M Brain Centroblastic lymphoma Extranodal lymphoma, AIDS
18 45 years M Lymph node Burkitt's lymphoma Extranodal lymphoma, AIDS
African lymphomas (Rwanda and Uganda)
19-26 Age, sex, and localization not always known Burkitt's lymphomas
Infectious mononucleosis
27 3 years F Tonsils Necrotizing polymorphic tonsillitis with
lymphoid hyperplasia
28 12 years M Lymph node Lymphadenitis with follicular
hyperplasia
29 26 years M Tonsils Acute tonsillitis
30 52 years M Tonsils Necrotizing lymphadenitis
31 19 years F Tonsils Acute tonsillitis
32 16 years F Tonsils Necrotizing tonsillitis
aAge in years unless otherwise indicated.
ISH in all the cases already positive in blotting assays
are listed in Table 2. In ISH studies two different pat-
terns were found. In IM, the EBV-positive cells are
distributed throughout the tissue section. Approxi-
mately 10 to 20% of the cells are labeled. These EBV-
positive cells are often gathered around areas ofnecro-
sis. Still, the majority ofthe paracortical lymphoid tis-
sue in IM cases remains unstained (Fig. 1).
The second patternisfoundinclassicalendemicBurk-
itt's lymphomas. All tumor cells are labeled in a ho-
mogeneous way. Each cell shows about the same num-
ber of silver grains. Starry sky macrophages, adjacent
structures, and vessels are not labeled and serve as an
endogeneous negative control (Fig. 2). Of the EBV-
positive AIDS-associated lymphomas, fourhave the ho-
mogeneous distribution pattern of EBV; in the three
remaining AIDS lymphomas the EBV distribution re-
sembles IM in that only some tumor cells are labeled
intensively and that these cells are scattered. But also
in the four lymphomas with a homogeneous EBV pos-
itivity there are some areas with a more scattered EBV
distribution.
Four children with inborn immunodeficiencies and
EBV-positive LPD had either polymorphic diffuse B-
cell hyperplasia (PDBH) or polymorphic B-cell lym-
phoma (PBL). In both the PDBH orthe PBL, the EBV
pattern was heterogeneous throughout all the tissues
investigated in each case. There were no differences
between lymphoma and lymphoid hyperplasia. One
PBL was monoclonal, the other polyclonal by immu-
nophenotyping.
All endemic African Burkitt's lymphomas had the ho-
mogeneous pattern. These lymphomas were from ma-
laria-free regions (Rwanda) aswell as fromregions with
endemic malaria.
Primary Extranodal Lymphomas
From oursample of539 cases, 37primarylymphomas
ofthe stomach and 7primarylymphomas ofthe salivary
glands were selected. Fourteen primary gastric lym-
phomas were ofthe mucosa-associated lymphoid tissue
(MALT) type (9), 18 werehigh-grade non-Hodgkin lym-
phomas (NHL). A summary ofinvestigations done and
the results obtained is given in Table 3.
Gastric lymphomas were considered EBV positive
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Table 2. Results of EBV-ISH in EBV-positive cases.
Case Diagnosis
Children with immune defects
1 SCID
2 Immune defect
3 SCID
4 Immunoblastic lymphoma
AIDS-associated lymphomas
5 T-immunoblastic lymphoma
6 Burkitt's lymphoma
7 Unclassified lymphoma
10 Burkitt's lymphoma
14 Burkitt's lymphoma
17 Centroblastic lymphoma
18 Burkitt's lymphoma
African lymphomas
19 Burkitt's lymphoma
20 Burkitt's lymphoma
21 Burkitt's lymphoma
22 Burkitt's lymphoma
23 Burkitt's lymphoma
24 Burkitt's lymphoma
25 Burkitt's lymphoma
26 Burkitt's lymphoma
Pattern of EBV-ISH
Heterogeneous Homogeneous
+
(+)a
(+)
+
(+)
(+)
+
+
+
+
+
+
+
+
+
+
+
Infectious mononucleosis
27-32 Necrotizing tonsillitis +
a(+) Indicates thatpartsofthetumorshowheterogeneous pattern.
when two assays (ISH and blotting) were positive.
Briefly, there are hints that EBV may be present in
some distinct extranodal NHL. This was found in acase
with ahigh-grade NHL andproliferation with Hodgkin-
like cells in the adjacent tissue (case 30003/86). In the
surrounding ofthe lymphoma, ISH revealed few EBV-
positive lymphoid cells. The nature of these cells re-
mains to be determined. The seven lymphomas of sal-
ivary glands (two high-grade and five low-grade NHL)
were negative for EBV.
T-Cell Lymphomas
In our material three cases ofT-cell lymphomas were
EBV positive. One case was a T-immunoblastic lym-
phoma occurring in AIDS (Table 1). A second case was
from a young African woman who developed a rapidly
growing anaplastic T-zone lymphoma. Finally, another
T-immunoblastic lymphoma in a immunocompetent pa-
tient showed the presence of EBV-genome.
Discussion
In addition to classical EBV-associated lesions [Burk-
itt's lymphoma (BL), IM, nasopharyngeal carcinoma]
other diseases of the lymphoid system seem to be re-
lated to EBV. Recently, the association of EBV with
T-cell lymphomas in patients with chronic EBV infec-
tions (4) has beenreported. We found EBVintwo NHL
ofthe T-phenotype where a chronic EBV infection has
notbeendocumentedbutcouldbe supposed, onepatient
having an acquired immunodeficiency and the other pa-
tient coming from central Africa, a region with numer-
ous environmental factors influencing the immune sys-
tem. These findings suggest that T-cell tumors possess
EBV DNA, which implies that T-cells support EBV-
replication (10).
On the other hand, we presented some evidence for
an involvement of EBV in the development of extra-
nodal lymphomas. Primary extranodal lymphomas of
the gastrointestinal tract have a histologically distinct
FIGURE 1. Paracortical lymphoid tissue in IM cases. In situ hybridization for EBV, '5S-labeled probe, x 510.
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FIGURE 2. Starry sky macrophages in Burkitt's lymphoma. In situ hybridization for EBV, 35S-labeled probe, x 510.
Table 3. Results of EBV studies in primary gastric lymphomas.
Case
H 30/86
H 32/86
H 14/86
H 359/86
H 1412/86
H 1580/86
18483/86
H 2244/86
H 2245/86
30003/86
H 183/87
H 274/87
H 588/87
H 640/87
H 2125/87
H 1923/87
H 2869/87
H 2951/87
H 3036/87
H 3229/87
9730/87
16928/87
30666/87
H 26/88
H 71/88
H 121/88
H 922/88
H 995/88
H 1007/88
H 1047/88
H 1140/88
H 1261/88
H 1262/88
H 1308/88
13847/88
17668/88
6544/89
aND, not determined.
Histologic diagnosis
MALT type
MALT type
Centroblastic
LP immunocytoma
Centroblastic
Lymphoblastic
MALT type
LP Immunocytoma
Immunoblastic-B
Centroblastic and HD
LP immunocytoma
Centroblastic
Early phase ofhigh-grade NHL
MALT type
MALT type
MALT type
Centroblastic
MALT type
MALT type
MALT type, early
Centroblastic
Centroblastic
Centroblastic
MALT type
T-lymphoma, early
Centroblastic
Centroblastic
Centroblastic
MALT type
MALT type
MALT type
Immunoblastic-B
MALT type
Centroblastic
Centroblastic
Centroblastic
MALT type
dot W
+
+
ND
ND
ND
ND
ND
ND
dot H
ND
ND
ND
ND
+
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
EBV genome
Southern
NDa
ND
ND
ND
ND
ND
ND
ND
ND
+
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
ISH
ND
ND
ND
ND
ND
ND
ND
-V K- -
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pattern (9) that has been called malignant lymphoma of
mucosa-associated lymphoidtissue (MALT)because the
accepted classifications of NHL were difficult to apply
to these tumors. The main component ofthese lympho-
masisthecentrocytelike cell(CCL), ofwhichthebenign
equivalent is characterized by a surface phenotype
IgM+, IgA+, CD 22+, CD 23-, CD 5-, and they are
positive for both CD 35 (CR1) and CD 21 (CR2), the B-
lymphocyte EBV receptor (11). We are actually inves-
tigating different forms of chronic gastritis with a pre-
ponderance of lymphoid cells for the presence of EBV
or viral proteins. Up to now, we have found one case
of EBV-positive gastric lymphoma, and so there may
be a link between MALT lymphocytes, EBV, and the
development of certain lymphomas. The fact that we
have only demonstrated EBV in one case of gastric
lymphoma could also be a question of sensitivity. Re-
cently, Saito et al. (12) clearly demonstrated EBV DNA
in tissue biopsies from patients with Sjogren's syn-
drome, a condition associated with the development of
lymphoid tissue in salivary glands and increased fre-
quency of NHL in these patients using the polymerase
chain reaction. Using a more sensitive method, the fre-
quency of EBV in primary extranodal lymphoma and
MALT tissue could be higher than is found with normal
blotting techniques.
In lymphomas and LPD of children with immunode-
ficiencies, as well as in lymphomas of patients with
AIDS, we demonstrated two different patterns: one
patterncouldbe calledthe IM-like patternandtheother
one the BL-like pattern. The interpretation of these
findings recalls the findings ofstudies with BL and lym-
phoblastoid cell lines (LCL) cell lines. LCL are derived
fromtheperipheralbloodofnormalseropositivedonors.
LCLs differ from BL lines in a number of phenotypic
characteristics. The LCLs represent the most likely
counterpart ofthe EBV-transformed blasts that prolif-
erate in IM (13). BL cells may represent the neoplastic
counterpart of latently infected normal B-cells with a
corresponding phenotype. The differences consist
mainly in viral gene expression and B-cell marker
expression. BL cells only express EBNA 1 and CALLA
and BLA, whereas LCLs express the full set ofEBNA
1-6 and LMP as well as-B activation markers (14). Our
finding oftwo different EBV genome patterns may re-
flect these two EBV-canrying cell types: the more ho-
mogeneous expression of EBV would then be related
to the BL phenotype; the scattered distribution occurs
when LCL-like cells are the predominant cell in the
lesion. This hypothesis could be tested by extensive
studies on viral gene expression and marker studies.
The acute phase of IM is comparable to a chaotic
attack of specific and nonspecific killer cells against a
multitude ofrapidlymultiplyingEBV-carryingB-blasts
(14). Our observation ofan IM-like pattern in PBL and
PDBH may be a further indication that the disease pro-
cess in these cases is an overwhelmingreaction to EBV
rather than an overwhelming infection (15).
The fact that EBV-positive AIDS lymphomas have
either IM-like or BL-like pattern indicates that there
may be two different groups of EBV lymphomas in
AIDS. It would be of interest to compare the clinical
outcome of the two lymphoma groups with diverging
EBV patterns.
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